Kaya (OTCMKTS:KAYS) is a global personal care company specializing in dermatological treatments and consumer skin- and hair-care products. Since its founding in 2003, the company has developed a reputation for combining medical expertise with spa-style services, offering a full spectrum of solutions for both aesthetic concerns and chronic skin conditions. Kaya’s integrated approach ensures that each client receives a tailored treatment plan, supported by a portfolio of proprietary skincare formulations designed to address issues such as acne, pigmentation, aging, and hair loss.
The company operates a network of medical spas and clinics under the Kaya Skin Clinic brand, staffed by certified dermatologists and trained skincare professionals. Services include advanced laser therapies, chemical peels, microdermabrasion, hair-rejuvenation treatments, and teledermatology consultations. In parallel with its in-clinic offerings, Kaya markets a range of over-the-counter products—such as cleansers, moisturizers, serums, and sunscreens—sold through its e-commerce platform and partnered retail outlets in key markets.
Kaya’s international footprint spans Asia, the Middle East, and Southeast Asia, with dedicated centers in markets such as India, the United Arab Emirates, Singapore, and Saudi Arabia. The company has continued to expand through a mix of company-owned clinics and strategic franchising arrangements, adapting its service menu and product lines to local regulatory requirements and consumer preferences. This geographic diversification supports a multi-channel distribution strategy that balances direct service revenues with recurring product sales.
Leadership at Kaya combines medical, scientific and consumer goods expertise. The executive team is led by CEO Anil Agarwal, who has over two decades of experience in the personal care industry, and Dr. Ritu Kapoor, the company’s Chief Medical Officer, who oversees clinical protocols and product development. Under their guidance, Kaya continues to invest in R&D, exploring advances in biotechnology and dermatological science to enhance treatment outcomes and broaden its product pipeline.
AI Generated. May Contain Errors.
Free KAYS Stock Alerts